Introduction

Healthcare organizations have an option, to some extent, to determine how connected they will be. With this in mind, please expand upon your answer to this week’s discussion by providing greater detail on how a move to big data for planning and decision-making would affect organizational internal and external policies. Specifically include privacy and security concerns, as well as the influence of accountable care in your response.
please provide 3 page answer for this question.

Thank you so much in advance

1) Explain the similarities and differences between the RBC and Dicty lanes.?

2) Explain how the Dicty-5 and Dicty-10 samples differ from each other and discuss whether this was what you expected to see.?

NOTE:

combine 5 ?l of your Dictyostelium sample and 95 ?l of 0.15N NaCl.

Dicty-5 is Dictyostelium discoideum cells.

Dicty-10 is Dictyostelium discoideum cells. ?just the value is change

The Summary Open Quiz is an opportunity for you to prepare for class and assess the knowledge and skills gained at the conclusion of class. These areas will be covered by your instructor. Use your reading and knowledge and skills to answer these questions and bring your written answers to class. Describe the regulatory requirements for discharge planning. Briefly discuss three important considerations in discharge planning. Explain how discharge planning provides continuity/transition of care and positive health outcomes. Identify the role nurses must play in discharge planning. What specific skills do nurses need to provide appropriate and effective discharge planning?

A. Please list and describe the FIVE neurotransmitters, according to this template:

Neurotransmitter #: ___________________________________

Description: _________________________________

B.Fill in the Blank

Please identify two neurotransmitters that are involved in both learning and memory.
Neurotransmitter 1: __________________________

Neurotransmitter 2: __________________________

Matthew Sanders is a 69-year-old male who is one day post-op following open radical prostatectomy for treatment of prostate cancer. PMH: presented to PCP two weeks ago with dysuria, hematuria and urinary hesitancy accompanied by back and pelvic discomfort that began six months ago. PSA level was 7.8 ng/mL and DRE showed enlarged prostate: asymmetric, hard and nontender. Biopsy confirmed prostate cancer Stage II, Gleason Score 8, classified as high-risk cancer. Osteoarthritis, Type 2 DM and history of peptic ulcer disease. 0700 Assessment • 130/90 98.8°F- 86-20 pulse oximetry 98% on room air 4/10 incisional pain • HRR, no edema, +2 peripheral pulses, capillary refill < 3 sec, elastic skin turgor, LR infusing at 125 mL/h via right forearm IPID • Abdomen soft, hypoactive bowel sounds x 4 quadrants, 500 mL green liquid emesis – ondansetron given at 2030 with relief of n/v, PO intake ice chips only, abdominal incision dry and intact • CBI infusing – pale pink color with occasional tiny clot, 600 mL urinary output for 11-7 shift, morphine given for bladder spasms at 0415 – pain score 7/10 to 4/10 d.

On first rounds, you discover urine is leaking around the foley catheter tubing. What will you do?

Later in the day, drainage in the foley bag has changed from pale pink to red with multiple clots. What are your next steps?

At the end of your shift, the PCA tells you that Mr. Sanders reports increased cramping and pain in his lower abdomen. What actions will you take?

How can electronic fetal monitoring inhibit the normal progress of labor? What can nurses do as advocates to counteract this effect?

1. Hypophysectomy-patient teaching and nursing considerations?
2. What is continuous bladder irrigation and what are your patient teaching and nursing considerations?

dicuss the topics and conditions in health organizations as it relates to permitted to use and disclosure Protected Health Information. What are some examples of when it is important to share information.

discuss the view that ethics and law is the engine that drives professionalism in health care practice

You are the privacy and security officer for your facility; your background is HIM and you are an RHIA with the Certified in Healthcare Privacy and Security (CHPS) credential. You are part of a team that is reviewing the RFPs received from various EHR vendors. Your emphasis in the review will be the privacy and security issues. You know that there are many privacy requirements, some of which are policy related; however, many impact the functionality of information systems. You are in the process of reviewing the RFPs that were returned to you be various EHR vendors. One of the RFPs states that they are HIPAA compliant, so you decide to comapare their product to the HIPAA security regulations to determine if this is true.

1. What privacy functions should you look for in the EHR?

2. What security functions should you look for in the EHR?

3. Is the fact that the vendor claims to be HIPAA compliant adequate for the system you choose?

Carlton Bates is a 62-year-old male with a family history of prostate cancer. He requested screening and his PSA level was 6.2 ng/mL. He chose to have a biopsy and is now meeting with an oncologist to discuss the results. The provider reports the biopsy was positive for malignancy: Stage 1, Gleason Score 5, classified as low risk, localized cancer. After listening to the options for treatment, Mr. Bates chooses active surveillance.

a. What measures are included in active surveillance for early, localized prostate cancer?

b. Why is this approach used with low risk patients?

c. What is a disadvantage of active surveillance?